1.山西医科大学,医学科学院,出生缺陷与细胞再生山西省重点实验室,山西太原
2.山西医科大学,煤炭环境致病与防治教育部重点实验室,出生缺陷与细胞再生山西省重点实验室,山西太原
3.山西医科大学,基础医学院生物化学与分子生物学教研室,出生缺陷与细胞再生山西省重点实验室,山西太原
4.吕梁市第一人民医院妇科,山西吕梁
Li Jianting,E-mail: lijianting2021@sxmu.edu.cn
Received:18 April 2026,
Revised:2026-06-17,
Accepted:06 July 2026,
Published:15 September 2026
移动端阅览
杨逸逍,高福梅,马雨琼,等.中国神经管畸形防控成效与隐忧并存:基于GBD 2023的1990—2023年疾病负担变迁与未来十年预测[J].陆军军医大学学报,2026,48(17):2418-2427.DOI:10.16016/j.2097-0927.202604067.
Yang Y X,Gao F M,Ma Y Q,et al.Achievements and hidden concerns in neural tube defect prevention and control in China: temporal trends in disease burden (1990 to 2023) and a 10-year forecasting based on GBD 2023[J].J Army Med Univ,2026,48(17):2418-2427.DOI:10.16016/j.2097-0927.202604067.
杨逸逍,高福梅,马雨琼,等.中国神经管畸形防控成效与隐忧并存:基于GBD 2023的1990—2023年疾病负担变迁与未来十年预测[J].陆军军医大学学报,2026,48(17):2418-2427.DOI:10.16016/j.2097-0927.202604067. DOI:
Yang Y X,Gao F M,Ma Y Q,et al.Achievements and hidden concerns in neural tube defect prevention and control in China: temporal trends in disease burden (1990 to 2023) and a 10-year forecasting based on GBD 2023[J].J Army Med Univ,2026,48(17):2418-2427.DOI:10.16016/j.2097-0927.202604067. DOI:
目的
2
神经管畸形(neural tube defects, NTDs)严重威胁围产期存活与远期生存质量。叶酸干预效果显著,但疾病负担的动态演变和残余风险尚未完全明确。通过分析1990—2023年中国NTDs负担的时间趋势、年龄-时期-队列效应及2024—2033年疾病负担预测,可明确干预重点方向。
方法
2
基于2023年全球疾病负担研究(Global Burden of Disease Study 2023,GBD 2023)数据库,提取中国NTDs的患病率、死亡率及伤残调整寿命年(disability-adjusted life years,DALYs)数据。采用GBD全球参考人口计算年龄标准化率(age-standardized rate,ASR)。运用Joinpoint回归模型识别时间趋势转折点,计算年度变化百分比(annual percent change,APC)和平均年度变化百分比(average annual percent change,AAPC)及95%
CI
。采用年龄-时期-队列模型,将1994—2023年数据划分为5年间隔(年龄组:
<
5岁至80~84岁;出生队列:1914—1918年至2019—2023年),评估年龄-时期-队列效应对NTDs患病率变化的贡献。应用自回归移动平均(autoregressive integrated moving average,ARIMA)模型预测2024—2033年中国NTDs的年龄标准化患病率(age-standardized prevalence rate,ASPR)、年龄标准化死亡率(age-standardized mortality rate,ASMR)及年龄标准化DALYs率(age-standardized DALYs rate,ASDR)。
结果
2
1990—2023年,中国NTDs的ASPR、ASMR和ASDR的AAPC分别为-0.90%(95%
CI
:-1.01%~-0.78%)、-8.51%(95%
CI
:-8.84%~-8.18%)和-7.89%(95%
CI
:-8.04%~-7.57%),总体呈显著下降趋势。Joinpoint回归显示,ASPR呈三段式波动:1990—2000年持续下降(1990—1995年:APC=-7.98%,
P
<
0.05;1995—2000年:APC=-4.80%,
P
<
0.05);2000—2019年总体回升(2000—2005年:APC=0.56%,
P
<
0.05;2005—2010年:APC=5.18%,
P
<
0.05;2010—2015年:APC=0.01%,
P
>
0.05;2015—2019年:APC=2.33%,
P
<
0.05);2019—2023年再次下降(APC=-0.23%,
P
<
0.05)。ASMR和ASDR均呈1990—1997年小幅上升(ASMR:APC=1.57%,
P
<
0.05;ASDR:APC=1.44%,
P
<
0.05)、1997—2021年持续下降(各阶段
P
均
<
0.05)、2021—2023年小幅回升(ASMR:APC=1.43%,
P
<
0.05;ASDR:APC=0.91%,
P
>
0.05)的三阶段特征。性别分层显示,男性ASPR始终高于女性;ASMR和ASDR在2004年前男性高于女性,2004年后女性反超男性。年龄分布方面,患病人数峰值在5~9岁,死亡人数和DALYs数高度集中于新生儿期(
<
1岁)。年龄-时期-队列模型显示,年龄效应以0~5岁婴幼儿期负担最重,随年龄增长快速下降;时期效应显示1994—2023年整体呈下降趋势,但2015年后效应减弱(
RR
由1999—2003年的0.91升至2019—2023年的1.30);队列效应方面:以1964年为参照,风险于早期队列处于较低水平,随后逐渐升高至1969—1973年达峰值,此后总体波动下降,2004—2008年降至近期低点后再次回升,2019—2023年略有回落。ARIMA模型预测2024—2033年ASPR、ASMR及ASDR均呈小幅上升趋势,至2033年分别达6.78/10万(95%
CI
:5.11~8.45)、0.12/10万(95%
CI
:-0.60~0.83)及12.37/10万(95%
CI
:-51.15~75.89)。
结论
2
1990—2023年中国NTDs疾病负担总体降幅显著,但患病率中期回升及未来预测上升趋势提示防控成效尚不稳固,需针对残余风险精准施策。对策 在巩固叶酸普服基础上实施精准分层干预;针对叶酸不应答人群探索肌醇等新型联合干预方式;强化高龄及高危人群围孕期叶酸监测与随访,扩大NTDs产前筛查服务的覆盖范围;在山西等高发省份建设“预防-筛查-干预”一体化示范区;利用队列数据构建风险预警模型,推动从普适增补向分层精准预防转变,并完善监测信息跨部门共享机制。
Objective
2
Neural tube defects (NTDs) pose a serious threat to perinatal survival and long-term quality of life. Although folic acid intervention has been effective
the dynamic evolution of disease burden and residual risks remain incompletely elucidated. By analyzing the temporal trends of NTDs burden in China from 1990 to 2023
age-period-cohort effects
and projections for 2024
-
2033
this study aims to identify priority directions for intervention.
Methods
2
Data on prevalence
mortality
and disability-adjusted life years (DALYs) of NTDs in China were extracted from the Global Burden of Disease (GBD) 2023 database. Age-standardized rates (ASRs) were calculated using the GBD global reference population. Joinpoint regression was employed to identify turning points in temporal trends
and annual percent change (APC)
and average annual percen
t change (AAPC)
with their 95% confidence intervals (
CI
). An age-period-cohort model was applied to data from 1994
-
2023
stratified into 5-year intervals (age groups:
<
5 years to 80-84 years; birth cohorts: 1914
-
1918 to 2019
-
2023)
to assess the contributions of age
period
and cohort effects to changes in NTDs prevalence. An autoregressive integrated moving average (ARIMA) model was employed to predict age-standardized prevalence rate (ASPR)
age-standardized mortality rate (ASMR)
and age-standardized DALY rate (ASDR) of NTDs in China from 2024 to 2033.
Results
2
From 1990 to 2023
the AAPC of ASPR
ASMR
and ASDR for NTDs in China was -0.90% (95%
CI
: -1.01% to -0.78%)
-8.51% (95%
CI
: -8.84% to -8.18%)
and -7.89% (95%
CI
: -8.04% to -7.57%)
respectively
indicating significant overall downward trends. Joinpoint regression analysis revealed a 3-phase fluctuation in ASPR: a continuous decline from 1990 to 2000 (1990
-
1995: APC=-7.98%
P
<
0.05; 1995
-
2000: APC=-4.80%
P
<
0.05); an overall rebound from 2000 to 2019 (2000
-
2005: APC=0.56%
P
<
0.05; 2005
-
2010: APC=5.18%
P
<
0.05; 2010
-
2015: APC=0.01%
P
>
0.05; 2015
-
2019: APC=2.33%
P
<
0.05); and another decline from 2019 to 2023 (APC=-0.23%
P
<
0.05). Both ASMR and ASDR exhibited a 3-stage pattern: a slight increase from 1990 to 1997 (ASMR: APC=1.57%
P
<
0.05; ASDR: APC=1.44%
P
<
0.05)
a sustained decline from 1997 to 2021 (all
P
<
0.05)
and a modest rebound from 2021 to 2023 (ASMR: APC=1.43%
P
<
0.05; ASDR: APC=0.91%
P
>
0.05). Sex-stratified analysis showed that ASPR was consistently higher in
males than in females; however
ASMR and ASDR were higher in males before 2004 but reversed to consistently higher in females after 2004. In terms of age distribution
the peak number of prevalent cases occurred in the 5
-
9 year age group
while deaths and DALYs were highly concentrated in the neonatal period (
<
1 year). The age-period-cohort model demonstrated that age effects were heaviest during infancy (0
-
5 years)
declining rapidly with increasing age; period effects showed an overall downward trend from 1994
-
2023
but weakened after 2015 (relative risk increased from 0.91 in 1999
-
2003 to 1.30 in 2019
-
2023); cohort effects
with 1964 as the reference
showed that risk was at a relatively low level in early cohorts
gradually rising to a peak in 1969
-
1973
followed by an overall fluctuating decline
dropping to a recent low in 2004
-
2008 before rebounding again
with a slight decline in 2019
-
2023. The ARIMA model projected a slight upward trend in ASPR
ASMR
and ASDR from 2024 to 2033
reaching 6.78/100 000 (95%
CI
: 5.11 to 8.45)
0.12/100 000 (95%
CI
: -0.60 to 0.83)
and 12.37/100 000 (95%
CI
: -51.15 to 75.89)
respectively
by 2033.
Conclusion
2
The overall burden of NTDs in China decreased substantially from 1990 to 2023
but the mid-term rebound in prevalence and the projected upward trend indicate that the gains in prevention and control remain fragile
necessitating targeted interventions addressing residual risks. Countermeasures Precision stratified interventions should be implemented on the foundation of consolidated universal folic acid supplementation; novel combined interventions such as inositol should be explored for folic acid non-responders; periconceptional folic acid monitoring and follow-up for advanced maternal age and high-risk populations should be strengthened
and the coverage of prenatal NTDs screening services expanded; integrated demonstration zones for “prevention-screening-intervention” should be established in high-prevalence provinces such as Shanxi; risk prediction models should be constructed using cohort data to promote the transition from universal supplementation to stratified precision prevention
and cross-departmental information sharing mechanisms for surveillance should be improved.
Greene N D E , Copp A J . Neural tube defects [J]. Annu Rev Neurosci , 2014 , 37 : 221 - 242 . DOI: 10.1146/annurev-neuro-062012-170354 http://dx.doi.org/10.1146/annurev-neuro-062012-170354 .
Liu H J , Chen K B , Wang T T , et al . Emerging trends and cross-country health inequalities in congenital birth defects: insights from the GBD 2021 study [J]. Int J Equity Health , 2025 , 24 ( 1 ): 50 . DOI: 10.1186/s12939-025-02412-7 http://dx.doi.org/10.1186/s12939-025-02412-7 .
MRC Vitamin Study Research Group . Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study [J]. Lancet , 1991 , 338 ( 8760 ): 131 - 137 . DOI: 10.1016/0140-6736(91)90133-A http://dx.doi.org/10.1016/0140-6736(91)90133-A .
任文彬 , 李建婷 , 解军 . 神经管闭合的新见解: 叶酸不应答型神经管畸形 [J]. 中国生物化学与分子生物学报 , 2024 , 40 ( 5 ): 575 - 587 . DOI: 10.13865/j.cnki.cjbmb.2024.03.1012 http://dx.doi.org/10.13865/j.cnki.cjbmb.2024.03.1012 .
Ren W B , Li J T , Xie J . New insights into neural tube closure: folic acid non-responsive neural tube defects [J]. Chin J Biochem Mol Biol , 2024 , 40 ( 5 ): 575 - 587 . DOI: 10.13865/j.cnki.cjbmb.2024.03.1012 http://dx.doi.org/10.13865/j.cnki.cjbmb.2024.03.1012 .
Kancherla V . Neural tube defects: a review of global prevalence, causes, and primary prevention [J]. Childs Nerv Syst , 2023 , 39 ( 7 ): 1703 - 1710 . DOI: 10.1007/s00381-023-05910-7 http://dx.doi.org/10.1007/s00381-023-05910-7 .
Zhang X L , Feng Y X , Ren J J , et al . Global, regional, and national burden of congenital heart disease, 1990—2021: a systematic analysis for the global burden of disease study 2021 [J]. Eur J Pediatr , 2025 , 184 ( 4 ): 253 . DOI: 10.1007/s00431-025-06085-w http://dx.doi.org/10.1007/s00431-025-06085-w .
Bai Z H , Han J R , An J , et al . The global, regional, and national patterns of change in the burden of congenital birth defects, 1990—2021: an analysis of the global burden of disease study 2021 and forecast to 2040 [J]. EClinicalMedicine , 2024 , 77 : 102873 . DOI: 10.1016/j.eclinm.2024.102873 http://dx.doi.org/10.1016/j.eclinm.2024.102873 .
Yang L , Wang H M , Xue L . What about the health workforce distribution in rural China? An assessment based on eight-year data [J]. Rural Remote Health , 2019 , 19 ( 3 ): 4978 . DOI: 10.22605/RRH4978 http://dx.doi.org/10.22605/RRH4978 .
Liu W , Liu Y , Twum P , et al . National equity of health resource allocation in China: data from 2009 to 2013 [J]. Int J Equity Health , 2016 , 15 : 68 . DOI: 10.1186/s12939-016-0357-1 http://dx.doi.org/10.1186/s12939-016-0357-1 .
Kim H J , Fay M P , Feuer E J , et al . Permutation tests for joinpoint regression with applications to cancer rates [J]. Stat Med , 2000 , 19 ( 3 ): 335 - 351 . DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z http://dx.doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z .
曾四清 . Joinpoint回归模型及其在传染病流行趋势分析中的应用 [J]. 中国卫生统计 , 2019 , 36 ( 5 ): 787 - 791 .
Zeng S Q . Joinpoint regression model and its application in the analysis of infectious disease epidemic trends [J]. Chin J Heal Stat , 2019 , 36 ( 5 ): 787 - 791 .
赵惠亮 , 陈隆 , 刘子豪 , 等 . 青少年与女性: 中美焦虑障碍与进食障碍疾病负担的共同高危人群: 基于GBD 2023的三十年趋势与预测分析 [J]. 陆军军医大学学报 , 2026 , 48 ( 11 ): 1607 - 1618 . DOI: 10.16016/j.2097-0927.202601040 http://dx.doi.org/10.16016/j.2097-0927.202601040 .
Zhao H L , Chen L , Liu Z H , et al . Adolescents and women: shared high-risk populations for the burden of anxiety disorders and eating disorders in China and the United States: a 30-year trend and predictive analysis based on GBD 2023 [J]. J Army Med Univ , 2026 , 48 ( 11 ): 1607 - 1618 . DOI: 10.16016/j.2097-0927.202601040 http://dx.doi.org/10.16016/j.2097-0927.202601040 .
Holford T R . The estimation of age, period and cohort effects for vital rates [J]. Biometrics , 1983 , 39 ( 2 ): 311 . DOI: 10.2307/2531004 http://dx.doi.org/10.2307/2531004 .
Luo L Y . Assessing validity and application scope of the intrinsic estimator approach to the age-period-cohort problem [J]. Demography , 2013 , 50 ( 6 ): 1945 - 1967 . DOI: 10.1007/s13524-013-0243-z http://dx.doi.org/10.1007/s13524-013-0243-z .
Rosenberg P S , Check D P , Anderson W F . A web tool for age-period-cohort analysis of cancer incidence and mortality rates [J]. Cancer Epidemiol Biomarkers Prev , 2014 , 23 ( 11 ): 2296 - 2302 . DOI: 10.1158/1055-9965.EPI-14-0300 http://dx.doi.org/10.1158/1055-9965.EPI-14-0300 .
Yu K Y , Cao C , An F L , et al . Analysis and contrast of psoriasis disease burden trends in China and globally from 1990 to 2021 [J]. Front Public Health , 2025 , 13 : 1541292 . DOI: 10.3389/fpubh.2025.1541292 http://dx.doi.org/10.3389/fpubh.2025.1541292 .
Lu V M . Global, regional, and national epidemiological trends in neural tube defects between 1990 and 2019: a summary [J]. Child’s Nerv Syst , 2023 , 39 ( 11 ): 3103 - 3109 . DOI: 10.1007/s00381-023-05985-2 http://dx.doi.org/10.1007/s00381-023-05985-2 .
Wu Y H , Chen L Z , Wang T T . Neural tube defects burden from 1992 to 2021: a global, regional, and national age-period-cohort analysis of disability-adjusted life years [J]. BMC Pediatr , 2026 , 26 ( 1 ): 418 . DOI: 10.1186/s12887-026-06587-y http://dx.doi.org/10.1186/s12887-026-06587-y .
Crider K S , Qi Y P , Yeung L F , et al . Folic acid and the prevention of birth defects: 30 years of opportunity and controversies [J]. Annu Rev Nutr , 2022 , 42 : 423 - 452 . DOI: 10.1146/annurev-nutr-043020-091647 http://dx.doi.org/10.1146/annurev-nutr-043020-091647 .
吕华胜 , 冀伟 , 孙丰宇 , 等 . 1990—2021年全球与中国新生儿先天性出生缺陷疾病负担趋势分析 [J]. 西安交通大学学报(医学版) , 2025 , 46 ( 6 ): 1045 - 1052 . DOI: 10.7652/jdyxb202506023 http://dx.doi.org/10.7652/jdyxb202506023 .
Lyu H S , Ji W , Sun F Y , et al . Trends in the disease burden of neonatal congenital birth defects in China and the globe, 1990—2021 [J]. J Xi’an Jiaotong Univ Med Sci , 2025 , 46 ( 6 ): 1045 - 1052 . DOI: 10.7652/jdyxb202506023 http://dx.doi.org/10.7652/jdyxb202506023 .
Agopian A J , Tinker S C , Lupo P J , et al . Proportion of neural tube defects attributable to known risk factors [J]. Birth Defects Res A Clin Mol Teratol , 2013 , 97 ( 1 ): 42 - 46 . DOI: 10.1002/bdra.23100 http://dx.doi.org/10.1002/bdra.23100 .
Correa A , Gilboa S M , Besser L M , et al . Diabetes mellitus and birth defects [J]. Am J Obstet Gynecol , 2008 , 199 ( 3 ): 237.e1 - 237.e9 . DOI: 10.1016/j.ajog.2008.06.028 http://dx.doi.org/10.1016/j.ajog.2008.06.028 .
Parker S E , Yazdy M M , Tinker S C , et al . The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina Bifida [J]. Am J Obstet Gynecol , 2013 , 209 ( 3 ): 239.e1 - 239.e8 . DOI: 10.1016/j.ajog.2013.05.047 http://dx.doi.org/10.1016/j.ajog.2013.05.047 .
Tanoshima M , Kobayashi T , Tanoshima R , et al . Risks of congenital malformations in offspring exposed to valproic acid in utero : a systematic review and cumulative meta-analysis [J]. Clin Pharma And Therapeutics , 2015 , 98 ( 4 ): 417 - 441 . DOI: 10.1002/cpt.158 http://dx.doi.org/10.1002/cpt.158 .
Finnell R H , Caiaffa C D , Kim S E , et al . Gene environment interactions in the etiology of neural tube defects [J]. Front Genet , 2021 , 12 : 659612 . DOI: 10.3389/fgene.2021.659612 http://dx.doi.org/10.3389/fgene.2021.659612 .
Poletta F A , Rittler M , Saleme C , et al . Neural tube defects: Sex ratio changes after fortification with folic acid [J]. PLoS One , 2018 , 13 ( 3 ): e0193127 . DOI: 10.1371/journal.pone.0193127 http://dx.doi.org/10.1371/journal.pone.0193127 .
Liu J F , Xie J , Li Z W , et al . Sex differences in the prevalence of neural tube defects and preventive effects of folic acid (FA) supplementation among five counties in northern China: results from a population-based birth defect surveillance programme [J]. BMJ Open , 2018 , 8 ( 11 ): e022565 . DOI: 10.1136/bmjopen-2018-022565 http://dx.doi.org/10.1136/bmjopen-2018-022565 .
Seller M J . Sex, neural tube defects, and multisite closure of the human neural tube [J]. Am J Med Genet , 1995 , 58 ( 4 ): 332 - 336 . DOI: 10.1002/ajmg.1320580406 http://dx.doi.org/10.1002/ajmg.1320580406 .
Maiz N , Arévalo S , Rodó C , et al . Investigating sex-based disparities in fetal spinal neural tube defects: an observational 12 Years-long study [J]. Early Hum Dev , 2026 , 217 : 106520 . DOI: 10.1016/j.earlhumdev.2026. 106520 http://dx.doi.org/10.1016/j.earlhumdev.2026.106520 .
Liu J F , Li Z W , Ye R W , et al . Periconceptional folic acid supplementation and sex difference in prevention of neural tube defects and their subtypes in China: results from a large prospective cohort study [J]. Nutr J , 2018 , 17 ( 1 ): 115 . DOI: 10.1186/s12937-018-0421-3 http://dx.doi.org/10.1186/s12937-018-0421-3 .
Deak K L , Siegel D G , George T M , et al . Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects [J]. Birth Defects Res A Clin Mol Teratol , 2008 , 82 ( 10 ): 662 - 669 . DOI: 10.1002/bdra.20511 http://dx.doi.org/10.1002/bdra.20511 .
Bendt M , Gabrielsson H , Riedel D , et al . Adults with spina Bifida : a cross-sectional study of health issues and living conditions [J]. Brain Behav , 2020 , 10 ( 8 ): e01736 . DOI: 10.1002/brb3.1736 http://dx.doi.org/10.1002/brb3.1736 .
Lundberg Larsen K , Maalen-Johansen I K , Rennie L , et al . Gait function in adults aged 50 years and older with spina Bifida [J]. Arch Phys Med Rehabil , 2021 , 102 ( 4 ): 702 - 708 . DOI: 10.1016/j.apmr.2020.10.118 http://dx.doi.org/10.1016/j.apmr.2020.10.118 .
Gattaz L , Ouellet M C , Turcotte S , et al . Changes and needs experienced by people aging with spina Bifida and Hydrocephalus [J]. Gerontologist , 2025 , 65 ( 6 ): gnaf101 . DOI: 10.1093/geront/gnaf101 http://dx.doi.org/10.1093/geront/gnaf101 .
沈愉歆 , 何守玉 , 邓闽军 , 等 . Wiltse入路经椎弓根椎体内植骨治疗胸腰椎退行性病变后凸畸形的矢状位脊柱平衡重建及临床疗效 [J]. 空军军医大学学报 , 2025 , 46 ( 9 ): 1195 - 1201, 1210 . DOI: 10.13276/j.issn.2097-1656.2025.09.014 http://dx.doi.org/10.13276/j.issn.2097-1656.2025.09.014 .
Shen Y X , He S Y , Deng M J , et al . Wiltse approach via pedicle screw intra vertebral bone grafting for sagittal spinal balance reconstruction and clinical efficacy in thoracolumbar degenerative kyphotic deformity [J]. J Air Force Med Univ , 2025 , 46 ( 9 ): 1195 - 1201, 1210 . DOI: 10.13276/j.issn.2097-1656.2025.09.014 http://dx.doi.org/10.13276/j.issn.2097-1656.2025.09.014 .
Williams V J , Treble-Barna A , Ware A L , et al . Spina Bifida and other neural tube defects [M]// APA handbook of neuropsychology, Volume 1: Neurobehavioral disorders and conditions: Accepted science and open questions (Vol. 1) . Washington : American Psychological Association , 2023 : 227 - 248 . DOI: 10.1037/0000307-011 http://dx.doi.org/10.1037/0000307-011 .
0
Views
10
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
